Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Harsaul Foundation | 10% Owner | 3 | $0 | $816.2K | 2023-10-20 |
| Altchem Ltd | 10% Owner | 3 | $0 | $816.2K | 2023-10-20 |
| Avista Healthcare Partners GP, Ltd. | 10% Owner | 1 | $0 | $0 | 2023-08-15 |
| Lask Alisa | Director | 3 | $0 | $0 | 2023-08-10 |
| DeBiasi Michael J. | Director | 1 | $0 | $0 | 2023-07-05 |
| COWAN GREGORY L | Director | 1 | $0 | $0 | 2023-07-05 |
| Klein Christopher | General Counsel & Secretary | 4 | $0 | $0 | 2023-05-18 |
| Schaub James | EVP and COO | 5 | $232.5K | $0 | 2023-05-18 |
| Orbit Co-Invest III LLC | 10% Owner | 2 | $12.40M | $0 | 2023-01-27 |
| Venkataraman Sriram | Director, 10% Owner | 2 | $12.40M | $0 | 2023-01-27 |
| Burgstahler David F | Director, 10% Owner | 2 | $12.40M | $0 | 2023-01-27 |
| MARKISON BRIAN A | Chief Executive Officer | 1 | $1.32M | $0 | 2022-08-08 |
| deVries Tina Marie | EVP, Research & Development | 2 | $0 | $0 | 2022-05-18 |
| Einhorn Andrew J. | Chief Financial Officer | 1 | $0 | $0 | 2022-01-24 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Altchem Ltd | 10% Owner | S Sale | 2023-10-20 | 2023-10-23 | 4,758,899 | $0.03 | $142.8K | 4,941,101 | SEC↗ |
| Harsaul Foundation | 10% Owner | S Sale | 2023-10-20 | 2023-10-23 | 4,758,899 | $0.03 | $142.8K | 4,941,101 | SEC↗ |
| Altchem Ltd | 10% Owner | S Sale | 2023-10-19 | 2023-10-23 | 9,363,760 | $0.05 | $468.2K | 9,700,000 | SEC↗ |
| Harsaul Foundation | 10% Owner | S Sale | 2023-10-19 | 2023-10-23 | 9,363,760 | $0.05 | $468.2K | 9,700,000 | SEC↗ |
| Altchem Ltd | 10% Owner | S Sale | 2023-10-18 | 2023-10-20 | 3,421,537 | $0.06 | $205.3K | 19,063,760 | SEC↗ |
| Harsaul Foundation | 10% Owner | S Sale | 2023-10-18 | 2023-10-20 | 3,421,537 | $0.06 | $205.3K | 19,063,760 | SEC↗ |
| Avista Healthcare Partners GP, | 10% Owner | J Other | 2023-08-15 | 2023-08-17 | 23,730,864 | — | $0 | 0 | SEC↗ |
| Lask Alisa | Director | F Tax w/h | 2023-08-10 | 2023-08-14 | 12,000 | $0.49 | $5.9K | 112,557 | SEC↗ |
| Lask Alisa | Director | A Award | 2023-07-05 | 2023-07-11 | 40,000 | — | $0 | 124,557 | SEC↗ |
| COWAN GREGORY L | Director | A Award | 2023-07-05 | 2023-07-11 | 40,000 | — | $0 | 90,055 | SEC↗ |
| DeBiasi Michael J. | Director | A Award | 2023-07-05 | 2023-07-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Klein Christopher | General Counsel & Secretary | F Tax w/h | 2023-05-18 | 2023-05-22 | 5,447 | $0.87 | $4.7K | 180,573 | SEC↗ |
| Schaub James | EVP and COO | F Tax w/h | 2023-05-18 | 2023-05-22 | 5,577 | $0.87 | $4.9K | 524,835 | SEC↗ |
| Orbit Co-Invest III LLC | 10% Owner | J Other | 2023-01-27 | 2023-01-30 | 1,032,995 | — | $0 | 0 | SEC↗ |
| Venkataraman Sriram | Director, 10% Owner | J Other | 2023-01-27 | 2023-01-30 | 1,032,995 | — | $0 | 0 | SEC↗ |
| Burgstahler David F | Director, 10% Owner | J Other | 2023-01-27 | 2023-01-30 | 1,032,995 | — | $0 | 0 | SEC↗ |
| Schaub James | EVP and COO | F Tax w/h | 2023-01-24 | 2023-01-26 | 9,608 | $1.26 | $12.1K | 530,412 | SEC↗ |
| Klein Christopher | General Counsel & Secretary | F Tax w/h | 2023-01-24 | 2023-01-26 | 9,608 | $1.26 | $12.1K | 186,020 | SEC↗ |
| Lask Alisa | Director | A Award | 2022-08-10 | 2022-08-12 | 75,000 | — | $0 | 84,557 | SEC↗ |
| Orbit Co-Invest III LLC | 10% Owner | P Buy | 2022-08-08 | 2022-08-09 | 8,000,000 | $1.55 | $12.40M | 23,730,864 | SEC↗ |
| Venkataraman Sriram | Director, 10% Owner | P Buy | 2022-08-08 | 2022-08-09 | 8,000,000 | $1.55 | $12.40M | 23,730,864 | SEC↗ |
| Burgstahler David F | Director, 10% Owner | P Buy | 2022-08-08 | 2022-08-09 | 8,000,000 | $1.55 | $12.40M | 23,730,864 | SEC↗ |
| MARKISON BRIAN A | Chief Executive Officer | P Buy | 2022-08-08 | 2022-08-09 | 850,000 | $1.55 | $1.32M | 2,976,020 | SEC↗ |
| Schaub James | EVP and COO | P Buy | 2022-08-08 | 2022-08-09 | 150,000 | $1.55 | $232.5K | 540,020 | SEC↗ |
| Schaub James | EVP and COO | F Tax w/h | 2022-05-18 | 2022-05-20 | 6,273 | $1.40 | $8.8K | 390,020 | SEC↗ |
| Klein Christopher | General Counsel & Secretary | F Tax w/h | 2022-05-18 | 2022-05-20 | 6,127 | $1.40 | $8.6K | 195,628 | SEC↗ |
| deVries Tina Marie | EVP, Research & Development | F Tax w/h | 2022-05-18 | 2022-05-20 | 5,447 | $1.40 | $7.6K | 136,141 | SEC↗ |
| Schaub James | EVP and COO | F Tax w/h | 2022-01-24 | 2022-01-26 | 9,607 | $1.13 | $10.9K | 396,293 | SEC↗ |
| deVries Tina Marie | EVP, Research & Development | F Tax w/h | 2022-01-24 | 2022-01-26 | 9,607 | $1.13 | $10.9K | 141,588 | SEC↗ |
| Klein Christopher | General Counsel & Secretary | F Tax w/h | 2022-01-24 | 2022-01-26 | 9,607 | $1.13 | $10.9K | 201,755 | SEC↗ |
| Einhorn Andrew J. | Chief Financial Officer | F Tax w/h | 2022-01-24 | 2022-01-26 | 9,607 | $1.13 | $10.9K | 141,473 | SEC↗ |